Wordt geladen...
Correction of Murine Hemophilia A by Hematopoietic Stem Cell Gene Therapy
A serious complication of current protein replacement therapy for hemophilia A patients with coagulation factor VIII (FVIII) deficiency is the frequent development of anti-FVIII inhibitor antibodies that preclude therapeutic benefit from further treatment. Induction of tolerance by persistent high-l...
Bewaard in:
Hoofdauteurs: | , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
2005
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2387180/ https://ncbi.nlm.nih.gov/pubmed/16226058 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2005.09.007 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|